Treat-and-extend Using Aflibercept for Type 3 Neovascularization

Clinical trial NCT04655482 · UNKNOWN

Trial details

NCT number: NCT04655482
Sponsor: Kim's Eye Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Retinal Angiomatous Proliferation

Start date: 2021-02-01
Primary completion: 2023-12-20
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.